Discussion and dialogue drive change
We are always open to your questions
- DEMECAN secures additional fundingDEMECAN – the German specialist for medical cannabis – has raised a […]
- COVID-19 restrictions impact the global supply chain: DEMECAN imports medicinal cannabis from the Netherlands to ensure supply.The German medicinal drug market is currently experiencing exceptional circumstances due to the global COVID-19 pandemic. Supply chain […]
- DEMECAN signs binding supply agreement with Australia-based medical cannabis producerDEMECAN announces the signing of a three-year supply agreement with […]
- DEMECAN receives approval for the distribution of cannabis flowers from the NetherlandsDEMECAN is pleased to announce receipt of AmRadV approval from […]
- btov and Single Family Office Invest in German Cannabis: 7 Million Euros for DEMECANThe btov Private Investor Network and a German Single Family […]
- DEMECAN Confirms Award for German Medical Cannabis ProductionBERLIN, May 27, 2019 DEMECAN Holding GmbH [“DEMECAN” or “The […]
WE ARE OPEN TO PRESS INQUIRIES
Only discussion and dialogue drive change. We are happy to receive your questions regarding our company, medical cannabis and the possibilities of phytopharmacological research.
If you are looking for an interview partner covering these topics, please contact us.